{"id":"tamsulosin-and-or-dutasteride","safety":{"commonSideEffects":[{"rate":"5-10%","effect":"Dysuria"},{"rate":"5-10%","effect":"Urinary frequency"},{"rate":"5-10%","effect":"Urinary urgency"},{"rate":"2-5%","effect":"Impotence"},{"rate":"2-5%","effect":"Ejaculation disorder"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Tamsulosin works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate. Dutasteride, on the other hand, blocks the conversion of testosterone to dihydrotestosterone (DHT), a hormone that contributes to prostate growth. By inhibiting DHT, dutasteride helps reduce prostate size and alleviate BPH symptoms.","oneSentence":"Tamsulosin and dutasteride are alpha-1 adrenergic receptor antagonists and 5-alpha-reductase inhibitors, respectively, used to treat benign prostatic hyperplasia (BPH) symptoms and reduce the risk of acute urinary retention and BPH-related surgery.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:37:31.253Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Benign prostatic hyperplasia (BPH) symptoms"},{"name":"Reducing the risk of acute urinary retention and BPH-related surgery"}]},"trialDetails":[{"nctId":"NCT07444385","phase":"PHASE1","title":"A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects","status":"RECRUITING","sponsor":"Addpharma Inc.","startDate":"2026-02-26","conditions":"Benign Prostatic Hyperplasia","enrollment":44},{"nctId":"NCT06282731","phase":"EARLY_PHASE1","title":"The Changes of Urine Growth Factors Level","status":"COMPLETED","sponsor":"En Chu Kong Hospital","startDate":"2013-05-31","conditions":"Benign Prostatic Hyperplasia","enrollment":74},{"nctId":"NCT06001619","phase":"PHASE4","title":"Prostate Medication, Metabolism and Gut Microbiota","status":"RECRUITING","sponsor":"Turku University Hospital","startDate":"2022-12-01","conditions":"Prostatic Hyperplasia, Prostate Cancer","enrollment":100},{"nctId":"NCT04245566","phase":"PHASE3","title":"Prostatic Artery Embolization vs. Pharmacotherapy for LUTS/BPH","status":"UNKNOWN","sponsor":"Dominik Abt","startDate":"2021-09","conditions":"Benign Prostatic Hyperplasia, Pharmacotherapy, Prostatic Artery Embolization","enrollment":425},{"nctId":"NCT02509104","phase":"PHASE1","title":"Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-07-30","conditions":"Prostatic Hyperplasia","enrollment":56},{"nctId":"NCT01495026","phase":"PHASE1","title":"A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-11-06","conditions":"Prostatic Hyperplasia","enrollment":63},{"nctId":"NCT00537654","phase":"PHASE1","title":"A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-10-18","conditions":"Prostatic Hyperplasia","enrollment":81},{"nctId":"NCT01332487","phase":"","title":"Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-08","conditions":"Prostatic Hyperplasia","enrollment":4068},{"nctId":"NCT01386983","phase":"","title":"Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-03","conditions":"Prostatic Hyperplasia","enrollment":332},{"nctId":"NCT01435954","phase":"","title":"Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-08","conditions":"Benign Prostatic Hyperplasia","enrollment":13551},{"nctId":"NCT00090103","phase":"PHASE3","title":"Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2003-11","conditions":"Prostatic Hyperplasia","enrollment":4844},{"nctId":"NCT00244309","phase":"PHASE3","title":"Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2005-11","conditions":"Prostate Cancer","enrollment":348}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3575,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"tamsulosin and/or dutasteride","genericName":"tamsulosin and/or dutasteride","companyName":"Case Comprehensive Cancer Center","companyId":"case-comprehensive-cancer-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tamsulosin and dutasteride are alpha-1 adrenergic receptor antagonists and 5-alpha-reductase inhibitors, respectively, used to treat benign prostatic hyperplasia (BPH) symptoms and reduce the risk of acute urinary retention and BPH-related surgery. Used for Benign prostatic hyperplasia (BPH) symptoms, Reducing the risk of acute urinary retention and BPH-related surgery.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}